Rising C-Reactive Protein and Procalcitonin Levels Precede Early Complications After Esophagectomy by Hoeboer, S.H. (Sandra) et al.
ORIGINAL ARTICLE
Rising C-Reactive Protein and Procalcitonin Levels
Precede Early Complications After Esophagectomy
Sandra H. Hoeboer & A. B. Johan Groeneveld &
Noel Engels & Michel van Genderen &
Bas P. L. Wijnhoven & Jasper van Bommel
Received: 19 July 2014 /Accepted: 5 January 2015 /Published online: 7 February 2015
# 2015 The Author(s). This article is published with open access at Springerlink.com
Abstract
Background Elective esophagectomy with gastric tube reconstruction carries a high risk for complications. Early and accurate
diagnosis could improve patient management. Increased C-reactive protein (CRP) levels may be associated with any, surgical or
infectious, complication and procalcitonin (PCT) specifically with infectious complications.
Methods We measured CRP and PCT on post-operative days 0, 1, 2, and 3 in 45 consecutive patients. Complications were
recorded up to 10 days post-esophagectomy.
Results Twenty-eight patients developed a post-operative complication (5 surgical, 14 infectious, 9 combined surgical/infectious,
including anastomotic leakage), presenting on day 3 or later. Elevated days 2 and 3 and a rise in CRP preceded the diagnosis of
general or combined surgical/infectious complications (minimum area under the receiver operating characteristics curve
(AUROC) 0.75, P=0.006). Elevated day 3 PCT preceded combined complications (AUROC 0.86, P<0.001). High day 1 and
3 PCT levels preceded anastomotic leakage (minimum AUROC 0.76, P=0.005), as did the day 3 CRP levels and their increases
(minimum AUROC 0.78, P=0.002).
Conclusions This small study suggests that high or increasing CRP levels may precede the clinical diagnosis of general or
surgical/infectious complications after esophagectomy. Elevated PCT levels may more specifically and timely precede combined
surgical/infectious complications mainly associated with anastomotic leakage.
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Abbreviations
AUROC Area under the receiver operator characteris-
tics curve
APACHE II
score
Acute Physiology and Chronic Health Eval-
uation II score
ASA
classification
American Society of Anesthesiologists
classification
CRP C-reactive protein
CV Coefficient of variation
ICU Intensive care unit
PCT Procalcitonin
P-POSSUM Portsmouth Physiological and Operative Se-
verity Score for the enUmeration ofMortality
and morbidity
SIRS Systemic inflammatory response syndrome
SOFA score Sequential Organ Failure Assessment score
WHO World Health Organization
Introduction
Early complications after elective esophagectomy and gastric
tube reconstruction are associated with increased morbidity
and mortality.1–5 Recognition of patients at risk for complica-
tions before presentation of full-blown symptoms could lead
to early diagnosis and treatment which may improve outcome.
However, the early recognition of complications by clinical
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characteristics and parameters in individual patients remains
difficult, except perhaps for pulmonary complications.2,3,6
Esophagectomy in itself induces a strong inflammatory re-
sponse, and the value of systemic inflammatory response
syndrome (SIRS) criteria fever, leukocytosis, tachypnea, and
tachycardia for the early diagnosis of complications is
limited.6–8 On the other hand, inflammatory biomarkers
like C-reactive protein (CRP) and procalcitonin (PCT)
might be useful in the early diagnosis of not yet clini-
cally symptomatic post-operative complications. Previous
studies reported an association between elevated CRP
levels and (infectious) complications, sepsis, and mortal-
ity after esophagectomy.8–12 However, CRP levels did
not discriminate between surgical and infectious compli-
cations, requiring different therapeutic management
strategies.6,8–10,12,13 PCT is an allegedly more specific
marker of severe infection and complications after sur-
gery than CRP,14–16 but the literature is inconclusive in
this respect.17,18 So far, only five studies reported on
PCT levels post-esophagectomy,1,11,13,19,20 of which only
t w o f o c u s e d o n p o s t - o p e r a t i v e i n f e c t i o u s
complications.11,13 The latter studies suggested that
PCT is useful for the diagnosis of infectious complica-
tions and discriminating sepsis from SIRS post-esopha-
gectomy. The discriminating ability of PCT for compli-
cation subtypes is unknown, however.
We hypothesized that CRP is a sensitive but non-specific
marker of developing complications after esophagectomy,
while PCT is a more specific marker of developing severe
post-operative infections. We thus compared the use of CRP
and PCT for early diagnosis of surgical and infectious
complications.
Patients and Methods
This prospective observational study, approved by the
Medical Ethical Committee of the Erasmus Medical Centre
(MEC-2010-199), was conducted between September 2011
and December 2012. Forty-five consecutive adult patients
were included after giving written informed consent prior
to surgery. We did not perform a power analysis for this
proof of principle study. Because of competing studies and
activities, this proof of principle study was limited in time,
and therefore, we could include only 45 patients in the
time interval indicated. Esophagectomy and gastric tube
reconstruction was performed by the transthoracic or
transhiatal approach.21 The gastric tube reconstruction
was performed by handsewn end-to-end or semimechanical
end-to-side anastomosis.22 After admission to the intensive
care unit (ICU), patients were taken care of by board-
certified intensivists unaware of biomarker results.
Study Protocol Upon ICU admission (day 0), baseline patient
characteristics were recorded. Disease severity was estimated
using the Acute Physiology and Chronic Health Evaluation II
(APACHE II) score, and organ failure was calculated by the
Sequential Organ Failure Assessment (SOFA) score. The
preoperative risk assessment was done by using the American
Society of Anesthesiologists (ASA) classification and Ports-
mouth predictor modification of the Physiological and Oper-
ative Severity Score for the enUmeration of Mortality and
morbidity (P-POSSUM). Clinical parameters and blood sam-
ples for routine laboratory parameters, leukocyte counts, and
CRP and PCT levels were collected directly post-operatively
on ICU admission (day 0) and in the morning of post-
operative days 1, 2, and 3. Leukocyte counts were measured
using the Sysmex SE-9000 analyzer (Toa Medical Instru-
ments, Kobe, Japan), and normal values are 3.5–10×109/L.
CRP was measured by an immunoturbidimetric assay (Mod-
ular analytics <P> Roche diagnostics, Mannheim, Germany),
and normal values are <9 mg/L. PCTwas measured using the
PCT sensitive for the Kryptor compact system (Brahms
Diagnostica, Hennigsdorf, Germany). Assays were performed
according to the manufacturer’s guidelines, the lower detec-
tion limit being 0.02 ng/mL, with an upper limit in healthy
volunteers of 0.05 ng/mL. The functional assay sensitivity
(FAS) of this test is 0.06 ng/mL, with an intra-assay coefficient
of variation (CV) and inter-assay CV of <6 % in samples
containing >0.3 ng/mL.
Definitions All complications up to 10 days post-
esophagectomy as decided by attending physicians were re-
corded, only if additional medical or surgical treatment was
required, notably grade 2 or higher on the Accordion Severity
Grading System.4,5 The definitions of complications used in
this study are depicted in Table 1. The 10-day cutoff was
chosen based on a previous study from this group.12 Infections
were defined according to the International Sepsis Forum
Consensus Conference criteria,23 as agreed upon by the at-
tending intensivists. Diagnostic imaging and collection of
specimens and blood for microbial culture were left at the
attending intensivist’s discretion. Specimens were processed
according to standardized culture protocols, and Gram stains
were prepared. Cultures reflecting colonization rather than
infection were excluded from final analysis. For example,
blood cultures containing coagulase-negative staphylococci
were considered contaminated if only one bottle showed
growth. Because reporting of definite culture results can take
several days, the day of specimen collection was considered
the day of infection diagnosis. Patients were considered to
have sepsis when presenting at least two SIRS criteria: body
temperature <36 °C or >38.3 °C, heart rate >90 bpm, respi-
ratory rate >20 breaths/min or mechanical ventilation, and a
leukocyte count of either <4.0×109/L or >12.0×109/L, in the
presence of a probable or proven infection, according to the
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American College of Chest Physicians/Society of Critical
Care Medicine guidelines.24 Shock was defined by a systolic
pressure <90 mmHg or a mean arterial pressure <60 mmHg
for at least 1 h, despite adequate fluid resuscitation, or require-
ment of vasopressor support to maintain mean arterial pres-
sure. Shock in the presence of sepsis was considered septic
shock. We report 30-day mortality.
Statistical Analysis Patients were categorized into two groups,
i.e., patients developing complications and without complica-
tions. In addition, to translate the results to clinical recommen-
dations and to reflect complication severity, patients with post-
operative complications were categorized into three mutually
exclusive complication groups. Patients could either have
purely surgical complications, purely infectious complica-
tions, or combined surgical and infectious complications. We
studied biomarker levels at days 0–3 and their fractional
change (Δ) at day 3, i.e., day 3 divided by day 0 biomarker
levels. Since most symptoms of complications appear after
post-operative day 3, the levels measured between days 0 and
3 were considered early diagnostic for complications present-
ing between days 4 and 10. We used IBM SPSS statistics for
Windows version 20 (IBM SPSS, Chicago, IL, USA) to
analyze the data, except for analyzing the area under the
receiver operating characteristics curve (AUROC). We pres-
ent data as median (inter-quartile range) since many continu-
ous data were non-normally distributed (Kolmogorov-
Smirnov test, P<0.05). We used a Kruskal-Wallis test and
Mann-Whitney U test to study group differences in continu-
ous variables and the X2 or Fisher exact test for categorical
variables. To evaluate the early diagnostic value of biomarker
levels for groups, we calculated the AUROCs, for which non-
Gaussian data were logarithmically transformed. Only the
AUROC analyses were performed using MedCalc for
Table 1 Definition of complications
Complication Definition
Surgical
Anastomotic
leakage
Esophagoenteric leak confirmed by endoscopy
or esophageal contrast videography that
requires local treatment, surgical treatment,
or removal of conduit.
Pleural effusion Pleural effusion confirmed by radiology
that requires drainage.
Chyle leak Chylomicrons in pleura aspirate or milky
discharge from chest tube at initiation
of enteral feeding.
Laryngeal nerve
palsy
Clinically suspected vocal cord paralysis
confirmed by laryngoscopy.
Conduit ischemia/
necrosis
Circular conduit ischemia/necrosis
confirmed by endoscopy and/or surgically
that requires local treatment or removal
of conduit.
Thromboembolic
disease
Deep venous thrombosis or pulmonary embolus.
Infectious
Pneumonia New infiltrate on chest radiograph and positive
tracheal aspirate cultures that requires
antibiotic treatment.
Empyema Pleural effusion on chest radiograph and positive
culture of aspirated specimen that requires
antibiotic and radiological or surgical treatment.
Abscess Intra-thoracic (mediastinal) or intra-abdominal
abscess confirmed by radiology with positive
culture of aspirated specimen that
requires antibiotic, radiological,
or surgical treatment.
Wound infection Erythematous wound, with effluent of pus
and/or positive culture that requires
opening of wound and antibiotics.
Gastrointestinal Stool culture positive for microbial pathogens
that requires antibiotic treatment.
Urinary tract Positive urine culture and urine sediment
that require antibiotic treatment.
Bacteremia Blood samples showing positive growth
and/or positive Gram stain, not reflecting
colonization that requires antibiotic treatment.
Patients could suffer from multiple complications simultaneously
Table 2 Complications up to 10 days post-esophagectomy
Surgical
complication
(N=5)
Infectious
complication
(N=14)
Combined surgical/infectious
complication (N=9)
Anastomotic
leak
Pneumonia,
wound
infection
Anastomotic leak, chyle leak,
wound infection
Anastomotic
leak
Pneumonia,
wound
infection
Anastomotic leak, pneumonia,
wound infection
Pleural
effusion,
chyle leak
Pneumonia Anastomotic leak, pneumonia
Chyle leak Pneumonia Anastomotic leak, abscess,
wound infection
Chyle leak Pneumonia Anastomotic leak, pleural effusion,
abscess, wound infection
Pneumonia Anastomotic leak, pneumonia
Pneumonia Anastomotic leak, wound infection,
pneumonia, empyema
Pneumonia Anastomotic leak, pneumonia,
empyema
Pneumonia Chyle leak, abscess, pneumonia
Wound infection
Wound infection
Wound infection
Urinary tract
infection
Urinary tract
infection
Complications presented no sooner than day 3; in 92 % of cases, com-
plications presented on day 4 or after
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Windows, version 13 (MedCalc Software, Ostend, Belgium).
We considered an AUROC ≥0.70 as clinically relevant. The
optimal diagnostic cutoff value was calculated as suggested by
Zweig and Campbell.25 To calculate the optimal criterion, this
method takes the disease prevalence and cost of true- and
false-positive and true- and false-negative decisions into
account.25 The Holm-Bonferroni method was used to correct
for multiple testing.26 We used multiple logistic regression
with backward selection of logarithmically transformed bio-
marker levels to study their interdependency for the diagnosis
of post-operative complications in general, complication sub-
types, and anastomotic leakage. We performed the Hosmer-
Lemeshow test to evaluate the goodness of fit. All tests were
two-sided, and P values<0.05 were considered statistically
significant; exact P values are given unless <0.001.
Results
Twenty-eight patients (62 %) suffered from a post-operative
complication, of whom 5 had a surgical complication, 14 an
infectious complication, and 9 combined surgical/infectious
complications (Table 2). The manifestation of post-operative
complications was on day 3 or later in all patients, and in 92%
of cases, complications presented on day 4 or later. Patients
developing combined surgical/infectious complications had
more complications than patients in the other complication
groups (3 vs. 1 complication). Table 3 shows baseline charac-
teristics for patients developing complications and without
complications. The number of female patients was higher in
the infectious and combined surgical/infectious than that in
the surgical complication group. Almost all patients suffered
from SIRS at some point during the first 10 days post-opera-
tively. Patients developing infectious complications had re-
ceived antibiotics less often than the other patient groups.
Patients suffering surgical or combined complications had a
longer hospital stay than patients with an uncomplicated re-
covery (P=0.03 and P=0.02, respectively). All patients sur-
vived until 30 days post-operatively. The preoperative World
Health Organization (WHO) performance score and pulmo-
nary function tests were not predictive of post-operative com-
plications. To avoid major overlap, we do not separately report
the baseline characteristics of patients with versus without
anastomotic leak.
Biomarker Levels Prior toDiagnosis of Complications Figure 1
shows the data (days 0–3) for patients developing any
complication and those without complications. Only sta-
tistically significant AUROC values are presented in Ta-
ble 4. The day 3 leukocyte counts were higher in patients
developing any complication than in those without, but
the optimal cutoff value in AUROC was below the upper
limit of the normal range. The day 2 and 3 CRP levels and
their rise were higher in patients developing complica-
tions than in those without and had diagnostic value with
high sensitivities of optimal cutoff values. The fractional
change of CRP levels on day 3 vs. day 0 in patients
developing complications was 46 (91) and in patients
without complications 19 (27), P=0.04. PCT levels could
not discriminate between patients developing any type of
complication and those without.
Biomarker Levels Prior to Diagnosis of Complication
Subtypes Figure 2 shows the data (days 0–3) for complication
subtypes. On day 3, leukocyte counts were higher in patients
with combined surgical/infectious complications than those
without complications (P=0.01). The CRP levels on days 2
and 3 were higher in patients with infectious complications
than in those without complications (P=0.03), whereas day 3
CRP levels were higher in patients with combined complica-
tions than in those without (P=0.01). The fractional increase
in CRP was higher in patients developing combined compli-
cations, by 76 (41), than in patients without complications, by
19 (27), P=0.02. On day 3, PCT levels were higher in patients
developing combined surgical/infectious complications than
in those without complications and developing surgical or
infectious complications (P=0.009).
Figure 3 shows the data (days 0–3) for patients with anas-
tomotic leakage versus patients with other complications or
without complications. On day 2, CRP levels were higher in
patients developing other complications than anastomotic
leakage compared to those without complications (P=0.02).
However, on day 3, the CRP levels were higher in patients
developing anastomotic leak compared to all patients (N=35)
without leakage (P=0.02). The PCT levels on days 1 and 3
were higher in patients with anastomotic leakage compared to
all patients (N=35) without leakage (P=0.02 and P=0.03,
respectively). Furthermore, the day 1 PCT levels were higher
in patients with anastomotic leakage vs. other complications
(P=0.02).
The diagnostic value of elevated day 3 PCT preceded
the clinical diagnosis of combined complications and anas-
tomotic leakage, as did the day 3 CRP levels and their
fractional changes (Table 4). The diagnostic value of high
day 1 PCT levels already preceded anastomotic leakage,
however.
Multiple Logistic Regression On day 2, CRP was diagnostic
for developing complications independently from leukocytes
and PCT (P=0.038, Hosmer-Lemeshow X2 5.22, df 8, P=
0.734). On day 3, CRP levels were diagnostic for developing
anastomotic leakage independently from leukocytes and PCT
(P=0.032, Hosmer-Lemeshow X2 8.8, df 7,P=0.268). On day
1, PCT was diagnostic for developing anastomotic leak inde-
pendently from leukocytes and CRP (P=0.016, Hosmer-
Lemeshow X2 8.064, df 8, P=0.427).
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Table 3 Baseline characteristics
Uncomplicated Complicated
(N=17) (N=28) P1 Surgical (N=5) Infectious (N=14) Combined surgical/
infectious (N=9)
P2
Sex (M) 16 (94) 23 (82) 0.39 2 (40) 12 (86) 9 (100) 0.009
Age (years) 62 (14) 63 (17) 0.52 60 (15) 65 (14) 63 (20) 0.89
BMI (cm2/kg) 27.8 (4.7) 23.8 (5.0) 0.05 22.7 (8.3) 25.3 (6.1) 23.5 (2.9) 0.12
WHO performance score
0 7 (41) 14 (50) 0.57 7 (50) 2 (40) 5 (56) 0.57
1 10 (59) 14 (50) 7 (50) 3 (60) 4 (44)
Preoperative pulmonary function
FEV1 (% predicted) 113 (27) 98 (21) 0.04 96 (27) 100 (1) 94 (22) 0.19
VC (% predicted) 112 (28) 111 (16) 1.00 115 (17) 108 (2) 106 (22) 0.58
ASA class
I 2 (12) 10 (11) 0.86 2 (40) 0 1 (11) 0.08
II 13 (77) 20 (71) 1 (20) 11 (79) 8 (89)
III 2 (12) 5 (18) 2 (40) 3 (21) 0
P-POSSUM score 35 (10) 34 (5) 0.50 34 (3) 33 (8) 35 (3) 0.70
Cell type
Squamous cell carcinoma 2 (12) 9 (32) 0.28 4 (29) 2 (40) 3 (33) 0.85
Adenocarcinoma 13 (77) 18 (64) 6 (64) 3 (60) 6 (67)
Small cell neuroendocrine carcinoma 1 (6) 1 (4) 1 (6) 0 0
Miscellaneous 1 (6) 0 0 0 0
Clinical stage
T
1 1 (6) 0 0.10 0 0 0 0.26
2 2 (12) 5 (18) 2 (14) 1 (20) 2 (22)
3 11 (65) 19 (68) 12 (86) 3 (60) 4 (44)
4 3 (20) 0 0 0 0
Unknown 0 4 (14) 0 1 (20) 3 (33)
N
0 5 (29) 9 (32) 0.67 5 (36) 2 (40) 2 (22) 0.53
1 5 (29) 9 (32) 3 (21) 2 (40) 4 (44)
2 6 (35) 9 (32) 6 (43) 1 (20) 2 (22)
3 1 (6) 0 0 0 0
Unknown 0 1 (4) 0 0 1(11)
M
0 17 (100) 26 (93) 0.52 14 (100) 5 (100) 7 (78) na
Unknown 0 2 (7) 0 0 2 (22)
Neoadjuvant chemoradiotherapy 14 (82) 26 (93) 0.35 5 (100) 13 (93) 8 (89) 0.66
Surgical approach
TH 6 (35) 10 (36) 1.00 2 (40) 5 (36) 3 (33) 1.00
TT 11 (65) 18 (64) 3 (60) 9 (64) 6 (67)
Open procedure 16 (94) 25 (59) 1.00 12 (86) 5 (100) 8 (89) 0.74
Laparoscopic procedure 1 (6) 3 (11) 2 (14) 0 1 (11)
Hand sewn end-to-end 7 (41) 17 (61) 0.23 8 (57) 3 (60) 6 (67) 0.61
Semimechanical side-to-end 10 (59) 11 (39) 6 (43) 2 (40) 3 (33)
Operation duration (min) 414 (186) 383 (136) 0.40 383 (171) 382 (140) 410 (156) 0.79
Blood loss (mL) 1000 (800) 675 (869) 0.33 600 (765) 725 (794) 700 (960) 0.33
APACHE II score 8 (5) 8 (3) 0.47 8 (2) 7 (6) 9 (4) 0.82
SOFA score
Day 0 7 (2) 6 (4) 0.36 4 (3) 5 (3) 5(2) 1.00
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Table 3 (continued)
Uncomplicated Complicated
(N=17) (N=28) P1 Surgical (N=5) Infectious (N=14) Combined surgical/
infectious (N=9)
P2
Day 1 5 (3) 4 (5) 0.18 5 (2) 4 (6) 4 (2) 0.47
Day 2 3 (1) 3 (4) 0.92 3 (4) 2 (5) 4 (2) 0.97
Day 3 1 (2) 1 (4) 0.15 3 (2) 2 (3) 3 (5) 0.26
SIRS (days 0–10) 13 (77) 27 (96) 0.06 5 (100) 14 (100) 8 (89) 0.17
Sepsis (days 0–10) 0 17 (64) <0.001 0 11 (79) 6 (67) <0.001
Septic shock (days 0–10) 0 6 (21) 0.07 0 3 (21) 3 (33) 0.06
Prophylactic antibiotics i.o. 17 (100) 22 (100) na 5 (100) 14 (100) 9 (100) na
Antibiotics received (days 0–10) 4 (24) 20 (71) 0.002 10 (71) 3 (66) 7 (78) 0.02
Microbiology
Enterobacteriaceae 0 7 (25) 0.03 0 5 (36) 2 (22) 0.03
Pseudomonaceae 0 5 (18) 0.14 0 3 (21) 2 (22) 0.15
Staphylococcaceae 0 1 (4) 1.00 0 1 (7) 0 0.50
Streptococcaceae 0 1 (4) 1.00 0 0 1 (11) 0.25
Miscellaneous 0 6 (21) 0.07 0 3 (21) 3 (33) 0.06
Vasopressor need (days 0–10) 7 (40) 12 (43) 0.91 2 (40) 5 (36) 5 (56) 0.82
ICU days 3 (1) 3 (1) 0.64 3 (2) 4 (2) 3 (5) 0.43
In hospital days 12 (6) 16 (10) 0.007 20 (12) 15 (6) 19 (12) 0.02
30-day mortality 0 0 na 0 0 0 na
Median (inter-quartile range), number (percentage), where appropriate; P1 comparison of uncomplicated vs. complicated patients by Mann-Whitney U
or Fisher’s exact test where appropriate. P2 comparison of uncomplicated patient and all three complication groups by Kruskal-Wallis H or X2 test,
where appropriate
APACHE Acute Physiology and Chronic Health Evaluation, ASA class American Society of Anesthesiology physical status classification, BMI body
mass index, FEV1 forced expiratory volume in 1 s, VC vital capacity, ICU intensive care unit, i.o. intra-operatively, m male, na not applicable, P-
POSSUM Portsmouth Physiological and Operative Severity Score for the enUmeration of Mortality and morbidity, SIRS Systemic Inflammatory
Response Syndrome, SOFA Sequential Organ Failure Assessment, TH transhiatal, TT transthoracic, WHOWorld Health Organization
Table 4 Diagnostic values of biomarkers (days 0–3) for complications (up to day 10)
Cutoff AUROC P value SN SP PPV NPV
Diagnostic values for any complication
Leukocytes day 3 7.9×109/L 0.71 0.02 75 64 78 60
CRP day 2 100 mg/L 0.71 0.04 100 36 74 100
CRP day 3 68 mg/L 0.75 0.006 100 43 75 100
Δ CRP days 0–3 23 0.75 0.01 75 78 86 64
Diagnostic values for combined surgical/infectious complications
CRP day 3 316 mg/L 0.80 <0.001 0 100 - 84
Δ CRP days 0–3 81 0.77 0.008 40 90 50 86
PCT day 3 1.15 ng/mL 0.86 <0.001 38 100 100 81
Diagnostic values for anastomotic leak
CRP day 3 229 mg/L 0.78 0.002 71 84 50 93
Δ CRP days 0–3 55 0.82 <0.001 80 80 50 94
PCT day 1 1.82 ng/mL 0.76 0.005 22 100 100 83
PCT day 3 0.35 ng/mL 0.86 <0.001 67 80 55 87
AUROC area under the receiver operating characteristics curve,CRPC-reactive protein,NPV negative predictive value, PCT procalcitonin,PPV positive
predictive value, SN sensitivity, SP specificity, Δ fractional change (day 3 divided by day 0 value)
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Fig. 1 Early leukocyte and
plasma biomarker levels (median
and inter-quartile range) for com-
plications up to 10 days after
elective esophagectomy. Without
complications (N=17) (circle),
with complications (N=28)
(square). CRP C-reactive protein,
PCT procalcitonin. P values refer
to Mann-Whitney U test
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Fig. 2 Early leukocyte and
plasma biomarker levels (median
and inter-quartile range) for com-
plications up to 10 days after
elective esophagectomy. Without
complications (N=17) (circle),
surgical complications (N=5)
(square), infectious complications
(N=14) (triangle), combined
surgical/infectious complications
(N=9) (inverted triangle). CRP
C-reactive protein, PCT
procalcitonin. P values refer to
Kruskal-Wallis test
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Fig. 3 Early leukocyte and
plasma biomarker levels (median
and inter-quartile range) for com-
plications up to 10 days after
elective esophagectomy. Without
complications (N=17) (circle),
with other complications (N=18)
(square), with anastomotic leak-
age (N=10) (triangle), CRP C-
reactive protein, PCT
procalcitonin. P values refer to
Kruskal-Wallis test
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Discussion
This relatively small study suggests that elevated CRP levels
are a sensitive marker of complications developing post-
esophagectomy, whereas elevated PCT levels may specifical-
ly indicate the development of more severe combined
surgical/infectious complications, mainly associated with
anastomotic leakage, within 3 to 10 days post-esophagectomy.
Even though all patients had low ASA classification, P-
POSSUM, and APACHE II scores, 62 % had early post-
operative complications. There were no fatalities within
30 days post-operatively. The preoperative risk assessment
scores were comparable between groups and thus unsuitable
for indicating development of a complicated post-operative
clinical course. Although the complication rate appears rela-
tively high, the rate and type are in line with the
literature.2–9,11–13,22,27,28 Up till now, there are no uniformly
accepted guidelines for reporting of post-operative complica-
tions, and a recent systematic review has shown a wide range
in definitions hampering interpretation of study results.4 The
difficulty in uniform, mutually exclusive complication cate-
gories makes interpretation and comparison of studies diffi-
cult. We grouped complications since they represent different
conditions and associated severities, whereas the group was
too small to attempt to discriminate between individual com-
plications. Patients who developed combined surgical/
infectious complications had more complications simulta-
neously than patients in the other complication groups. Fur-
thermore, their hospital stay was longer than of patients with
infectious complications or without complications.
This is the first study trying to discriminate among early
post-operative complication types by using CRP and PCT. All
complications presented on day 3 or later, and in 92 % of
cases, complications presented on day 4 or later. We may
argue that since the cutoff values of day 2 and 3 biomarker
levels precede the clinical symptoms and diagnosis of com-
plication, they are predictive in time. The elevation of CRP
levels in patients without complications is also comparable to
that reported before.6,8,9,11–13 Studies reported high PCT
levels, as in our study, after esophagectomy or other extensive
gastrointestinal surgeries irrespective of complications,1,15,19
and high PCT levels, albeit not more elevated than CRP, in
major anastomotic leakage after colorectal surgery.16,18 Based
on our observations and those of others,6,7,9,12,15,17 one
may thus hypothesize that both CRP and PCT increase
following a surgical host response, but that PCT follows
a more severe manifestation of this response, particularly
when associated with surgical/infectious complications.
Indeed, we could not discriminate infectious complica-
tions from surgical complications by use of PCT or CRP,
but PCT rather than CRP was able to identify patients at
risk for more severe combined complications after
esophagectomy.
In detail, CRP levels on days 2 and 3 were diagnostic for
any complication presenting between days 3 and 10, indepen-
dent of preoperative risk assessment score and SIRS criteria.
The calculated sensitivity and specificity are similar to those
reported in some previous studies,9,10 but in slight contrast to
others who found a diagnostic value of CRP no sooner than on
post-operative day 48,11,12 or no diagnostic value at all for
anastomotic leakage or infectious complications.6,13 In our
study, neither CRP levels nor fractional increases could dif-
ferentiate between complication groups, limiting the use of
CRP levels for early recognition of complication subtypes.
The low specificity and modest positive predictive value
calculated from the AUROC suggest that the use of an elevat-
ed CRP alone as an indicator of developing complications
post-esophagectomy may lead to antibiotic overtreatment,
amongst others, if considered specific for infection.
Plasma PCT levels have been studied and compared
with CRP in patients after major surgery and trauma, but
the results are inconclusive.14–18,20 So far, one study on
post-esophagectomy showed a diagnostic value of PCT
for development of sepsis11 and another one for infec-
tious complications.13 We found an early diagnostic val-
ue of day 3 PCT levels for combined surgical/infectious
complications presenting between days 3 and 10 inde-
pendently from preoperative risk assessment scores, but
not of infectious complications alone. PCT was the only
marker of help in the early diagnosis of more severe
complications and the earliest one to recognize anasto-
motic leakage, the most common combined surgical/
infectious complication. Even though the AUROC of
day 3 CRP was statistically significant for combined
complications, the marker level had little positive predic-
tive value. The positive predictive value of PCT levels is
higher, and PCT is therefore preferred over CRP for
diagnosis of combined complications. As a result, elevat-
ed PCT levels at the cutoff levels presented could guide
additional diagnostics and start of empirical antibiotics
before full-blown presentation of complications post-
esophagectomy.
The leukocyte counts peaked around the upper limit of
normal on day 2 in agreement with some studies.6,8,10,11 This
relatively low leukocyte peak count could be explained by
neoadjuvant chemotherapy in the majority of patients. Some
investigators found a moderately elevated leukocyte count on
days 2 to 5 to predict anastomotic leak and infectious
complications.8,10,11 The leukocyte count in our study did
not discriminate between surgical, infectious, or combined
complications and is therefore not useful for this purpose, as
in other studies.6,13 We included this SIRS criterion for rea-
sons of comparison with CRP and PCT.
The limitations of this proof of principle study include its
relatively small and heterogeneous sample size. Furthermore,
li t t le is known about the effects of neoadjuvant
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chemoradiotherapy on biomarker release and kinetics. How-
ever, almost all patients in our study received such treatment
and predictive values of biomarkers were maintained. There is
no difference in effect on post-operative CRP and PCT values
reported between laparoscopic and open surgery or between
the transhiatal and transthoracic approaches, respectively.1,29
Conclusion An increasing or high CRP level within 3 days
after elective esophagectomy may contribute to the early
diagnosis of any post-operative complications presenting be-
tween post-operative days 3 and 10, independent of the pre-
operative risk assessment scores. Elevated PCT levels may
specifically indicate severe combined surgical/infectious com-
plications, mainly associated with anastomotic leakage, but
may not recognize infectious complications alone. Neverthe-
less, PCT rather than CRP might be used for decisions on
additional diagnostics and empirical antibiotic treatment in
these patients.
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